Poly-γ-Glutamate microneedles as transdermal immunomodulators for ameliorating atopic dermatitis-like skin lesions in Nc/Nga mice

Acta Biomaterialia - Tập 114 - Trang 183-192 - 2020
Mei-Chin Chen1, Chia-Sui Chen1, Yan-Wei Wu2, Yin-Yin Yang1
1Department of Chemical Engineering, National Cheng Kung University, Tainan, Taiwan
2Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan

Tài liệu tham khảo

Lee, 2014, Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis, Allergy Asthma Immunol. Res., 6, 276, 10.4168/aair.2014.6.4.276 Egawa, 2016, Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march, J. Allergy Clin. Immunol., 138, 350, 10.1016/j.jaci.2016.06.002 Weidinger, 2018, Atopic dermatitis, Nat. Rev. Dis. Primers, 4, 1, 10.1038/s41572-018-0001-z Thomsen, 2014, Atopic dermatitis: natural history, diagnosis, and treatment, ISRN Allergy, 2014, 10.1155/2014/354250 Karuppagounder, 2016, Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis, Drug Discov. Today., 21, 632, 10.1016/j.drudis.2016.02.011 Egawa, 2016, Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march, J. Allergy Clin. Immunol., 138, 350, 10.1016/j.jaci.2016.06.002 Paller, 2019, The atopic march and atopic multimorbidity: Many trajectories, many pathways, J. Allergy Clin. Immunol., 143, 46, 10.1016/j.jaci.2018.11.006 De Benedetto, 2015, Histamine and skin barrier: are histamine antagonists useful for the prevention or treatment of atopic dermatitis?, J. Clin. Med., 4, 741, 10.3390/jcm4040741 Brewer, 2019, Antagonistic effects of IL-4 on IL-17A-mediated enhancement of epidermal tight junction function, Int. J. Mol. Sci., 20, 4070, 10.3390/ijms20174070 Werfel, 2016, Cellular and molecular immunologic mechanisms in patients with atopic dermatitis, J. Allergy Clin. Immunol., 138, 336, 10.1016/j.jaci.2016.06.010 Lee, 2014, Oral administration of poly-γ-glutamate ameliorates atopic dermatitis in Nc/Nga mice by suppressing Th2-biased immune response and production of IL-17A, J. Invest. Dermatol., 134, 704, 10.1038/jid.2013.389 Kang, 2017, Theobroma cacao extract attenuates the development of Dermatophagoides farinae-induced atopic dermatitis-like symptoms in NC/Nga mice, Food Chem, 216, 19, 10.1016/j.foodchem.2016.07.141 Park, 2019, Gardenia jasminoides extract without crocin improved atopic dermatitis-like skin lesions via suppression of Th2-related cytokines in Dfe-induced NC/Nga mice, J. Ethnopharmacol, 241, 10.1016/j.jep.2019.112015 Kabashima, 2013, New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity, J. Dermatol. Sci., 70, 3, 10.1016/j.jdermsci.2013.02.001 Jang, 2018, Atopic dermatitis-like skin lesions are suppressed in fat-1 transgenic mice through the inhibition of inflammasomes, Exp. Mol. Med., 50, 73, 10.1038/s12276-018-0104-3 Amin, 2012, The role of mast cells in allergic inflammation, Respir. Med., 106, 9, 10.1016/j.rmed.2011.09.007 Tempark, 2010, Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature, Endocr, 38, 328, 10.1007/s12020-010-9393-6 Eichenfield, 2014, Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies, J. Am. Acad. Dermatol., 71, 116, 10.1016/j.jaad.2014.03.023 Broeders, 2016, Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience, J. Am. Acad. Dermatol., 75, 410, 10.1016/j.jaad.2016.02.1228 Siegfried, 2013, Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice, Am. J. Clin. Dermatol., 14, 163, 10.1007/s40257-013-0020-1 Sung, 2005, Natural and edible biopolymer poly-gamma-glutamic acid: synthesis, production, and applications, Chem. Rec., 5, 352, 10.1002/tcr.20061 Chettri, 2016, Poly-γ-glutamic acid (PGA)-producing bacillus species isolated from Kinema, Indian fermented soybean food, Front. Microbiol, 7, 971, 10.3389/fmicb.2016.00971 Yoon, 2000, Production of poly-γ-glutamic acid by fed-batch culture of Bacillus licheniformis, Biotechnol. Lett., 22, 585, 10.1023/A:1005625026623 Buescher, 2007, Microbial biosynthesis of polyglutamic acid biopolymer and applications in the biopharmaceutical, biomedical and food industries, Crit. Rev. Biotechnol., 27, 1, 10.1080/07388550601166458 Kim, 2007, Oral administration of high molecular mass poly-gamma-glutamate induces NK cell-mediated antitumor immunity, J. Immunol, 179, 775, 10.4049/jimmunol.179.2.775 Lee, 2009, Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect, Cancer Immunol. Immunother, 58, 1781, 10.1007/s00262-009-0689-4 Park, 2016, iNKT cells are responsible for the apoptotic reduction of basophils that mediate Th2 immune responses elicited by papain in mice following γ-PGA stimulation, PLoS One, 11 Sialdcr, 1993, Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the european task force on atopic dermatitis, Dermatology, 186, 23, 10.1159/000247298 Gupta, 2011, Kinetics of skin resealing after insertion of microneedles in human subjects, J. Control. Release, 154, 148, 10.1016/j.jconrel.2011.05.021 Chen, 2018, Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design, Acta Biomater, 65, 66, 10.1016/j.actbio.2017.11.004 Su, 2017, Efficient delivery of nanoparticles to deep skin layers using dissolvable microneedles with an extended-length design, J. Mater. Chem. B, 5, 3355, 10.1039/C7TB00451F Lahiji, 2015, A patchless dissolving microneedle delivery system enabling rapid and efficient transdermal drug delivery, Sci. Rep., 5, 7914, 10.1038/srep07914 Chen, 2015, Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin, Acta Biomater, 24, 106, 10.1016/j.actbio.2015.06.021 Kim, 2018, Significance of skin barrier dysfunction in atopic dermatitis, Allergy Asthma Immunol. Res, 10, 207, 10.4168/aair.2018.10.3.207 Czarnowicki, 2016, barrier repair and antimicrobial responses underlying this "inert" moisturizer, J. Allergy Clin. Immunol., 137, 1091, 10.1016/j.jaci.2015.08.013 Lindh, 2015, Clinical effectiveness of moisturizers in atopic dermatitis and related disorders: A systematic review, Am. J. Clin. Dermatol, 16, 341, 10.1007/s40257-015-0146-4 Kim, 2018, Polyelectrolyte complex nanofibers from poly(γ-glutamic acid) and fluorescent chitosan oligomer, Int. J. Biol. Macromol, 118, 238, 10.1016/j.ijbiomac.2018.06.035 Khalil, 2017, Bacterial-derived polymer poly-g-glutamic acid (γ-PGA)-based micro/nanoparticles as a delivery system for antimicrobials and other biomedical applications, Int. J. Mol. Sci., 18, E313, 10.3390/ijms18020313 Zhao, 2018, Transdermal immunomodulation: Principles, advances and perspectives, Adv. Drug Deliv. Rev., 127, 3, 10.1016/j.addr.2018.03.010 Matsuda, 1997, Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice, Int. Immunol., 9, 461, 10.1093/intimm/9.3.461 Jin, 2009, Animal models of atopic dermatitis, J. Invest. Dermatol, 129, 31, 10.1038/jid.2008.106 Vestergaard, 2000, The Nc/Nga mouse: a model for atopic dermatitis, Mol. Med. Today, 6, 209, 10.1016/S1357-4310(00)01683-X Nakamura, 2002, Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in Nc/Nga atopic mouse model, Gene Ther, 9, 1221, 10.1038/sj.gt.3301724 Chan, 2013, Effect of dehydroepiandrosterone on atopic dermatitis-like skin lesions induced by 1-chloro-2,4-dinitrobenzene in mouse, J. Dermatol. Sci., 72, 149, 10.1016/j.jdermsci.2013.06.015 Choi, 2016, Chemical composition and inhibitory effect of lentinula edodes ethanolic extract on experimentally induced atopic dermatitis in vitro and in vivo, Molecules, 21, E993, 10.3390/molecules21080993